Hiroshi Noto

4.3k total citations · 3 hit papers
78 papers, 3.0k citations indexed

About

Hiroshi Noto is a scholar working on Endocrinology, Diabetes and Metabolism, Molecular Biology and Surgery. According to data from OpenAlex, Hiroshi Noto has authored 78 papers receiving a total of 3.0k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Endocrinology, Diabetes and Metabolism, 30 papers in Molecular Biology and 14 papers in Surgery. Recurrent topics in Hiroshi Noto's work include Metabolism, Diabetes, and Cancer (25 papers), Diabetes Treatment and Management (17 papers) and Diabetes Management and Research (15 papers). Hiroshi Noto is often cited by papers focused on Metabolism, Diabetes, and Cancer (25 papers), Diabetes Treatment and Management (17 papers) and Diabetes Management and Research (15 papers). Hiroshi Noto collaborates with scholars based in Japan, United States and Australia. Hiroshi Noto's co-authors include Mitsuhiko Noda, Atsushi Goto, Tetsuro Tsujimoto, Hideki Origasa, Tatsuya Kondo, Eiichi Araki, Yukihiro Fujita, Daisuke Yabe, Masakazu Haneda and Takehiko Sasazuki and has published in prestigious journals such as PLoS ONE, The Journal of Clinical Endocrinology & Metabolism and Diabetes Care.

In The Last Decade

Hiroshi Noto

76 papers receiving 2.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Cancer Risk in Diabetic Patients Treated with Metformin: A Systematic Review and Meta-analysis

2012 453 citations Hiroshi Noto, Atsushi Goto et al. PLoS ONE profile →
Japanese Clinical Practice Guideline for Diabetes 2019

2020 380 citations Atsushi Goto, Mitsuhiko Noda et al. Diabetology International profile →
Japanese Clinical Practice Guideline for Diabetes 2016

2018 268 citations Mitsuhiko Noda, Hiroshi Noto et al. Diabetology International profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Hiroshi Noto Japan	25	1.4k	1.1k	554	476	459	78	3.0k
Wing Yee So Hong Kong	31	1.1k 0.8×	679 0.6×	372 0.7×	326 0.7×	167 0.4×	78	2.5k
Wenquan Niu China	32	605 0.4×	743 0.7×	488 0.9×	335 0.7×	339 0.7×	191	3.1k
Chris D. Poole United Kingdom	25	1.6k 1.1×	679 0.6×	403 0.7×	411 0.9×	299 0.7×	73	3.0k
Ilaria Dicembrini Italy	35	2.5k 1.7×	1.2k 1.1×	857 1.5×	333 0.7×	587 1.3×	87	3.3k
Minoru Yamakado Japan	33	619 0.4×	960 0.9×	358 0.6×	608 1.3×	307 0.7×	128	3.5k
Satinath Mukhopadhyay India	26	961 0.7×	862 0.8×	601 1.1×	680 1.4×	197 0.4×	150	3.2k
Sebastiano Squatrito Italy	33	2.4k 1.7×	1.2k 1.1×	824 1.5×	321 0.7×	500 1.1×	80	3.8k
И. И. Дедов Russia	34	2.3k 1.7×	818 0.8×	712 1.3×	341 0.7×	215 0.5×	451	4.2k
Linda Morrow United States	29	1.8k 1.3×	1.1k 1.0×	1.1k 2.1×	381 0.8×	397 0.9×	81	3.6k
Anneke C. Muller Kobold Netherlands	37	746 0.5×	588 0.6×	641 1.2×	288 0.6×	308 0.7×	123	3.5k

Countries citing papers authored by Hiroshi Noto

Since Specialization

Citations

This map shows the geographic impact of Hiroshi Noto's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hiroshi Noto with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hiroshi Noto more than expected).

Fields of papers citing papers by Hiroshi Noto

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hiroshi Noto. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hiroshi Noto. The network helps show where Hiroshi Noto may publish in the future.

Co-authorship network of co-authors of Hiroshi Noto

This figure shows the co-authorship network connecting the top 25 collaborators of Hiroshi Noto. A scholar is included among the top collaborators of Hiroshi Noto based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hiroshi Noto. Hiroshi Noto is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yamakage, Hajime, Hisashi Kato, Ryo Suzuki, et al.. (2025). Antidiabetic agents and dementia risk in type 2 diabetes: A systematic review and network meta‐analysis. Diabetes Obesity and Metabolism. 28(1). 256–264.

Goto, Atsushi, Ken Ohashi, Mitsuhiko Noda, et al.. (2024). Third Report of the Japan Diabetes Society (JDS)/Japanese Cancer Association (JCA) Joint Committee on diabetes and cancer: summary of the results of a questionnaire survey of oncologists and diabetologists—secondary publication. Diabetology International. 15(1). 5–18.

Goto, Atsushi, Ken Ohashi, Mitsuhiko Noda, et al.. (2024). Third Report of the Japan Diabetes Society/Japanese Cancer Association Joint Committee on Diabetes and Cancer: Summary of the results of a questionnaire survey of oncologists and diabetologists—Secondary publication. Cancer Science. 115(2). 672–681. 1 indexed citations

Kobayashi, Daiki, Hiroshi Noto, Osamu Takahashi, & Takuro Shimbo. (2019). Glycemic variability and subsequent malignancies among the population without diabetes. Diabetes Research and Clinical Practice. 159. 107987–107987. 8 indexed citations

Tsujimoto, Tetsuro, Ritsuko Yamamoto‐Honda, Hiroshi Kajio, et al.. (2016). Accelerated decline of renal function in type 2 diabetes following severe hypoglycemia. Journal of Diabetes and its Complications. 30(4). 681–685. 4 indexed citations

Tsujimoto, Tetsuro, Takehiro Sugiyama, Ritsuko Yamamoto‐Honda, et al.. (2016). Beneficial effects through aggressive coronary screening for type 2 diabetes patients with advanced vascular complications. Medicine. 95(33). e4307–e4307. 3 indexed citations

Noto, Hiroshi, Atsushi Goto, Tetsuro Tsujimoto, & Mitsuhiko Noda. (2015). Emerging Link between Diabetes and Cancer. Journal of General and Family Medicine. 16(3). 170–176. 1 indexed citations

Hayashi, Toshio, Kiyoshi Kubota, Seinosuke Kawashima, et al.. (2014). Efficacy of HMG-CoA reductase inhibitors in the prevention of cerebrovascular attack in 1016 patients older than 75 years among 4014 type 2 diabetic individuals. International Journal of Cardiology. 177(3). 860–866. 3 indexed citations

Imai, Kenjiro, Miyako Kishimoto, Tetsuro Tsujimoto, et al.. (2013). Successful Treatment of Chronic Intractable Itching Using Oral Pregabalin in a Patient with Diabetes and Systemic Prurigo Nodularis: A Case Report of an Iliopsoas Muscle Abscess. Internal Medicine. 52(23). 2629–2633. 7 indexed citations

10.

Kasuga, Masato, Kohjiro Ueki, Naoko Tajima, et al.. (2013). Report of the Japan Diabetes Society/Japanese Cancer Association joint committee on diabetes and cancer. Cancer Science. 104(7). 965–976. 60 indexed citations

11.

Noto, Hiroshi, Atsushi Goto, Tetsuro Tsujimoto, & Mitsuhiko Noda. (2013). Low-Carbohydrate Diets and All-Cause Mortality: A Systematic Review and Meta-Analysis of Observational Studies. PLoS ONE. 8(1). e55030–e55030. 155 indexed citations

12.

Noto, Hiroshi, et al.. (2013). Latest insights into the risk of cancer in diabetes. Journal of Diabetes Investigation. 4(3). 225–232. 65 indexed citations

13.

Noto, Hiroshi, et al.. (2013). Effect of calcium channel blockers on incidence of diabetes: a meta-analysis. Diabetes Metabolic Syndrome and Obesity. 6. 257–257. 28 indexed citations

14.

Tsujimoto, Tetsuro, Hiroshi Kajio, Yoshihiko Takahashi, et al.. (2011). Asymptomatic coronary heart disease in patients with type 2 diabetes with vascular complications: a cross-sectional study. BMJ Open. 1(2). e000139–e000139. 15 indexed citations

15.

Noto, Hiroshi, Tetsuro Tsujimoto, & Mitsuhiko Noda. (2011). Significantly increased risk of cancer in diabetes mellitus patients: A meta‐analysis of epidemiological evidence in Asians and non‐Asians. Journal of Diabetes Investigation. 3(1). 24–33. 51 indexed citations

16.

Noto, Hiroshi, et al.. (2010). Substantially increased risk of cancer in patients with diabetes mellitus. Journal of Diabetes and its Complications. 24(5). 345–353. 91 indexed citations

17.

Noto, Hiroshi, et al.. (2006). The role of lipoprotein-associated phospholipase A2 in the metabolic syndrome and diabetes. Journal of Diabetes and its Complications. 20(6). 343–348. 32 indexed citations

18.

Iso-O, Naoyuki, Hiroshi Noto, Masumi Hara, et al.. (2005). Adenovirus-mediated gene transfer and lipoprotein-mediated protein delivery of plasma PAF-AH ameliorates proteinuria in rat model of glomerulosclerosis. Molecular Therapy. 13(1). 118–126. 4 indexed citations

19.

Mizutani, Shigehiko, et al.. (1982). Inactivation of oxytocin and angiotensin II by placental leucine aminopeptidase (P-LAP).. PubMed. 34(4). 545–7. 2 indexed citations

20.

Mizutani, Shigehiko, et al.. (1979). ESTIMATION OF PLACENTAL LEUCINE IN ABNORMAL PREGNANCY AMINOPEPTIDASE SERA. 日本産科婦人科學會雜誌. 31(4). 493–498. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact